If you have any question, please feel free to email us. We will touch with you as soon as possible.
CAS:102767-28-2
Source:India
Qualifications:USDMF/CEP/-/-/-
Name | Levetiracetam |
---|---|
Chinese name | 左乙拉西坦 |
Cas Number | 102767-28-2 |
Source | India |
Qualifications | USDMF/CEP/-/-/- |
""Levetiracetam is an anti-epileptic drug developed by Utimes. The drug is a pyrrolidone derivative with central selectivity. It regulates neurotransmitter release by participating in vesicle polymerization and exocytosis. Play a role. In recent years in clinical applications at home and abroad, Levetiracetam has shown definite anti-epileptic efficacy and good tolerability. In addition to being used for adjuvant treatment of refractory epilepsy, its indications are also It gradually expands to the field of single-drug therapy for newly diagnosed epilepsy and the prevention and treatment of epileptic seizures after surgery, with broad application prospects. Imported raw materials, with great price advantage, stable supply, long-term supply in large quantities, and support for joint declaration""
Hot Tags: levetiracetam api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Tetrabenazine API, Fondaparinux API, Clofarabine API, Bivalrudine API, Edoxaban API, Bemeprost API
Tel:+86-020-61855200-902
Fax:+86-020-66392525
Email:info@upharm.cn
Address:12th floor, No. 181, Kexue Avenue, Huangpu District, Guangzhou, China